Carcinoembryonic Antigen (Cea) Market Share, Trends Worldwide Forecast 2016
- Submitted by: sank
- Views: 82
- Category: Science
- Date Submitted: 01/29/2016 01:30 AM
- Pages: 4
- Report this Essay
Global carcinoembryonic antigen market is expected to reach USD 2.56 Billion by 2022. Constant technological advancements pertaining to the development of novel biomarkers which can be used in combination with other biomarkers is expected to boost usage rates over the forecast period. Furthermore, the increasing prevalence of cancer is expected to heighten the demand for effective diagnostic tools. According to the WHO estimates in 2012, global cancer incidences were nearly 14.1 million, which include 6.7 million female patients and 7.4 million male patients. Increasing demand for minimally invasive diagnostics procedures is also expected to play a vital role in determining market growth. Key advantages associated with minimally invasive diagnostics procedures include elevated patient satisfaction levels as they entail minor incision wounds. In addition, these procedures involve relatively lesser hospital stays and therefore, are economically viable and involve fewer post procedure complications.
Browse Detail Report With TOC @ http://www.hexareports.com/report/carcinoembryonic-antigen-cea-market-analysis-by-application-colorectal-pancreatic-ovarian-breast-thyroid-cancer-and-segment-forecasts-to-2022/details
Further key findings from the study suggest:
Colorectal cancer was one of the largest revenue generating application segment of the carcinoembryonic antigen market and was estimated at USD 639.65 million in 2014. Increasing prevalence of colorectal cancer and usage of carcinoembryonic antigen tests at various stages is one of the critical factors accounting for its large share. For instance, in 2012, new cases of colorectal cancer were estimated to be over 93,000 and death due to colorectal cancer is expected to be over 49,700 in the U.S alone.
Carcinoembryonic antigen based breast cancer diagnosis is identified as the most lucrative application segment of the market. The market is driven by factors such as growing number of female population above...
Browse Detail Report With TOC @ http://www.hexareports.com/report/carcinoembryonic-antigen-cea-market-analysis-by-application-colorectal-pancreatic-ovarian-breast-thyroid-cancer-and-segment-forecasts-to-2022/details
Further key findings from the study suggest:
Colorectal cancer was one of the largest revenue generating application segment of the carcinoembryonic antigen market and was estimated at USD 639.65 million in 2014. Increasing prevalence of colorectal cancer and usage of carcinoembryonic antigen tests at various stages is one of the critical factors accounting for its large share. For instance, in 2012, new cases of colorectal cancer were estimated to be over 93,000 and death due to colorectal cancer is expected to be over 49,700 in the U.S alone.
Carcinoembryonic antigen based breast cancer diagnosis is identified as the most lucrative application segment of the market. The market is driven by factors such as growing number of female population above...